insights_auto
Why is LONN up 4,73%?
Dive Deeperchevron_right
LONN:VIE
Lonza Group AG
654,80 €
arrow_upward
+4,73%(+29,60) 1D
15 қаз., 17:36:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONN...
Open
645,40 €
High
654,80 €
Low
644,80 €
Mkt. cap
42,40 млрд
Avg. vol.
0,00
Volume
0,00
52-wk high
654,80 €
52-wk low
499,60 €
No. of employees
20 мың
Open
645,40 €
High
654,80 €
Low
644,80 €
Mkt. cap
42,40 млрд
Avg. vol.
0,00
Volume
0,00
52-wk high
654,80 €
52-wk low
499,60 €
No. of employees
20 мың
News stories
From web sources and news partners
Nutraceutical Business Review
·
8 сағат бұрын
Lonza Capsugel to showcase plant-based Organicaps and advanced capsule technologies at SupplySide Global
ad-hoc-news.de
·
14 сағат бұрын
Lonza lifts mid-term margin goal as Lonza Group stock trades at EUR 645.30
TipRanks
·
1 күн бұрын
Lonza Raises Growth Targets After Completing Pure-Play CDMO Transformation
TradingView
·
1 күн бұрын
Lonza Upgrades Organic Growth Model And Mid-Term Financial Ambitions At Capital Markets Day
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20,1 мың
Founded1897
HeadquartersБазель, Базель-Штадт, Швейцария
Sector-
Websitelonza.com